Slideshow

Endo News Roundup: Diabetes and Cardiovascular Disease

Author(s):

Studies include drug-free remission of T2DM, and the impact of hyperglycemia and hypoglycemia on cardiovascular health.

Three new studies on T2DM highlight a combination of intensive lifestyle change and drug therapy and the risks of both hyperglycemia and hypoglycemia. T2DM patients who maintain a short course of intensive lifestyle and drug therapy that reduces weight and controls blood glucose may be able to enjoy several months of drug-free remission; a large population study that followed T2DM patients from diagnosis shows hyperglycemia remains as an essential risk factor for heart failure, as has been demonstrated in earlier studies; and on the other side of the coin, hypoglycemia risk is an indicator for cardiovascular disease (CVD) and death in older adults with T2DM.

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
© 2024 MJH Life Sciences

All rights reserved.